NewsBenzingaNeuroSense Therapeutics宣布纳斯达克听证会小组日期为11月10日;已重新符合最低买价要求;预计PrimeC里程碑将在12月和2027年第一季度达成 NeuroSense Therapeutics宣布纳斯达克听证会小组日期为11月10日;已重新符合最低买价要求;预计PrimeC里程碑将在12月和2027年第一季度达成 Benzinga 2026.10.13 12:38 (GMT+0) Open on Benzinga Other news Wells Fargo Maintains Equal-Weight on PENN Entertainment, Lowers Price Target to $22 HC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $85 Price Target Alphabet Stock Rises: What's Going On? $1000 Invested In Agilent Technologies 10 Years Ago Would Be Worth This Much Today Wells Fargo Maintains Equal-Weight on MGM Resorts International, Lowers Price Target to $29 Why Is Applied Digital Stock Surging on Monday?